Pluri Inc. (PLUR)
NASDAQ: PLUR
· Real-Time Price · USD
4.53
0.07 (1.46%)
At close: Sep 25, 2025, 3:59 PM
4.55
0.44%
After-hours: Sep 25, 2025, 04:00 PM EDT
1.46% (1D)
| Bid | 4.41 |
| Market Cap | 36.95M |
| Revenue (ttm) | 1.03M |
| Net Income (ttm) | -20.71M |
| EPS (ttm) | -3.56 |
| PE Ratio (ttm) | -1.27 |
| Forward PE | -1.72 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 4.99 |
| Volume | 5,354 |
| Avg. Volume (20D) | 11,552 |
| Open | 4.52 |
| Previous Close | 4.46 |
| Day's Range | 4.50 - 4.57 |
| 52-Week Range | 3.33 - 7.13 |
| Beta | 0.69 |
| Ex-Dividend Date | n/a |
About PLUR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PLUR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PLUR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Pluri has released their quartely earnings
on Sep 17, 2025:
Pluri Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
+4.76%
Pluri shares are trading higher after the company ...
Unlock content with
Pro Subscription
10 months ago
+11.84%
Brainstorm Cell Therapeutics and Pluri shares are trading higher after the companies entered into a memorandum of understanding to manufacture NurOwn for a Phase 3b trial in amyotrophic lateral sclerosis.
